Comparative clinicopathological and outcome analysis of differentiated thyroid cancer in Saudi patients aged below 60 years and above 60 years
Khalid Hussain AL-Qahtani,1 Mutahir A Tunio,2 Mushabbab Al Asiri,2 Yasser Bayoumi,3 Ali Balbaid,2 Naji J Aljohani,4 Hanadi Fatani5 1Department of Otolaryngology-Head & Neck Surgery, College of Medicine, King Saud University, Riyadh, Saudi Arabia; 2Department of Radiation Oncology, Comprehen...
Guardado en:
Autores principales: | , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://doaj.org/article/ff6fa28af47843d2b0fe0b45c897b11f |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:ff6fa28af47843d2b0fe0b45c897b11f |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:ff6fa28af47843d2b0fe0b45c897b11f2021-12-02T01:05:22ZComparative clinicopathological and outcome analysis of differentiated thyroid cancer in Saudi patients aged below 60 years and above 60 years1178-1998https://doaj.org/article/ff6fa28af47843d2b0fe0b45c897b11f2016-08-01T00:00:00Zhttps://www.dovepress.com/comparative-clinicopathological-and-outcome-analysis-of-differentiated-peer-reviewed-article-CIAhttps://doaj.org/toc/1178-1998Khalid Hussain AL-Qahtani,1 Mutahir A Tunio,2 Mushabbab Al Asiri,2 Yasser Bayoumi,3 Ali Balbaid,2 Naji J Aljohani,4 Hanadi Fatani5 1Department of Otolaryngology-Head & Neck Surgery, College of Medicine, King Saud University, Riyadh, Saudi Arabia; 2Department of Radiation Oncology, Comprehensive Cancer Center, King Fahad Medical City, Riyadh, Saudi Arabia; 3Department of Radiation Oncology, NCI, Cairo University, Cairo, Egypt; 4Department of Endocrinology and Thyroid Oncology, 5Histopathology, Comprehensive Cancer Center, King Fahad Medical City, Riyadh, Saudi Arabia Introduction: The aim of this study was to evaluate the treatment outcomes of differentiated thyroid cancer in Saudi patients aged above 60 years. Materials and methods: Comparative analysis was performed in 252 patients aged 46–60 years (Group A) and 118 patients aged above 60 years (Group B), who had thyroidectomy, radioactive iodine-131, and thyroid-stimulating hormone suppression therapy between July 2000 and December 2012. Different clinicopathological features, treatment, complications, disease-free survival, and overall survival rates were compared. Results: Mean age of patients in Group A was 51.9 years (range: 46–60), and mean age of those in Group B was 68.6 years (range: 62–97). Group B patients had higher positive lymph nodes (43.2%), P=0.011. The frequency of extrathyroidal extension, multifocality, and lymphovascular space invasion was seen more in Group B than in Group A. Postsurgical complications (permanent hypoparathyroidism, bleeding, and wound infections) were also seen more in Group B (P=0.043, P=0.011, and P=0.021, respectively). Group B patients experienced more locoregional recurrences (11.0%, P=0.025); similarly, more distant metastases were observed in Group B (15.3%, P=0.003). The 10-year disease-free survival rates were 87.6% in Group A and 70.8% in Group B (P<0.0001). Conclusion: Differentiated thyroid cancer in patients aged above 60 years are more aggressive biologically and associated with a worse prognosis, and the morbidity is significantly high as compared to patients aged below 60 years. Keywords: differentiated thyroid cancers, patients aged above 45 years, aged above 60 years, clinicopathological characteristics, treatment outcomes, elderly patients, aged below 60 years, comparative analysisAL-Qahtani KHTunio MAAsiri MABayoumi YBalbaid AAljohani NJFatani HDove Medical PressarticleDifferentiated thyroid cancerspatients aged above 45 yearsaged above 60 yearsage below 60 yearsclinicopathological characteristicstreatment outcomeselderly patients. comparative analysisGeriatricsRC952-954.6ENClinical Interventions in Aging, Vol Volume 11, Pp 1169-1174 (2016) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Differentiated thyroid cancers patients aged above 45 years aged above 60 years age below 60 years clinicopathological characteristics treatment outcomes elderly patients. comparative analysis Geriatrics RC952-954.6 |
spellingShingle |
Differentiated thyroid cancers patients aged above 45 years aged above 60 years age below 60 years clinicopathological characteristics treatment outcomes elderly patients. comparative analysis Geriatrics RC952-954.6 AL-Qahtani KH Tunio MA Asiri MA Bayoumi Y Balbaid A Aljohani NJ Fatani H Comparative clinicopathological and outcome analysis of differentiated thyroid cancer in Saudi patients aged below 60 years and above 60 years |
description |
Khalid Hussain AL-Qahtani,1 Mutahir A Tunio,2 Mushabbab Al Asiri,2 Yasser Bayoumi,3 Ali Balbaid,2 Naji J Aljohani,4 Hanadi Fatani5 1Department of Otolaryngology-Head & Neck Surgery, College of Medicine, King Saud University, Riyadh, Saudi Arabia; 2Department of Radiation Oncology, Comprehensive Cancer Center, King Fahad Medical City, Riyadh, Saudi Arabia; 3Department of Radiation Oncology, NCI, Cairo University, Cairo, Egypt; 4Department of Endocrinology and Thyroid Oncology, 5Histopathology, Comprehensive Cancer Center, King Fahad Medical City, Riyadh, Saudi Arabia Introduction: The aim of this study was to evaluate the treatment outcomes of differentiated thyroid cancer in Saudi patients aged above 60 years. Materials and methods: Comparative analysis was performed in 252 patients aged 46–60 years (Group A) and 118 patients aged above 60 years (Group B), who had thyroidectomy, radioactive iodine-131, and thyroid-stimulating hormone suppression therapy between July 2000 and December 2012. Different clinicopathological features, treatment, complications, disease-free survival, and overall survival rates were compared. Results: Mean age of patients in Group A was 51.9 years (range: 46–60), and mean age of those in Group B was 68.6 years (range: 62–97). Group B patients had higher positive lymph nodes (43.2%), P=0.011. The frequency of extrathyroidal extension, multifocality, and lymphovascular space invasion was seen more in Group B than in Group A. Postsurgical complications (permanent hypoparathyroidism, bleeding, and wound infections) were also seen more in Group B (P=0.043, P=0.011, and P=0.021, respectively). Group B patients experienced more locoregional recurrences (11.0%, P=0.025); similarly, more distant metastases were observed in Group B (15.3%, P=0.003). The 10-year disease-free survival rates were 87.6% in Group A and 70.8% in Group B (P<0.0001). Conclusion: Differentiated thyroid cancer in patients aged above 60 years are more aggressive biologically and associated with a worse prognosis, and the morbidity is significantly high as compared to patients aged below 60 years. Keywords: differentiated thyroid cancers, patients aged above 45 years, aged above 60 years, clinicopathological characteristics, treatment outcomes, elderly patients, aged below 60 years, comparative analysis |
format |
article |
author |
AL-Qahtani KH Tunio MA Asiri MA Bayoumi Y Balbaid A Aljohani NJ Fatani H |
author_facet |
AL-Qahtani KH Tunio MA Asiri MA Bayoumi Y Balbaid A Aljohani NJ Fatani H |
author_sort |
AL-Qahtani KH |
title |
Comparative clinicopathological and outcome analysis of differentiated thyroid cancer in Saudi patients aged below 60 years and above 60 years |
title_short |
Comparative clinicopathological and outcome analysis of differentiated thyroid cancer in Saudi patients aged below 60 years and above 60 years |
title_full |
Comparative clinicopathological and outcome analysis of differentiated thyroid cancer in Saudi patients aged below 60 years and above 60 years |
title_fullStr |
Comparative clinicopathological and outcome analysis of differentiated thyroid cancer in Saudi patients aged below 60 years and above 60 years |
title_full_unstemmed |
Comparative clinicopathological and outcome analysis of differentiated thyroid cancer in Saudi patients aged below 60 years and above 60 years |
title_sort |
comparative clinicopathological and outcome analysis of differentiated thyroid cancer in saudi patients aged below 60 years and above 60 years |
publisher |
Dove Medical Press |
publishDate |
2016 |
url |
https://doaj.org/article/ff6fa28af47843d2b0fe0b45c897b11f |
work_keys_str_mv |
AT alqahtanikh comparativeclinicopathologicalandoutcomeanalysisofdifferentiatedthyroidcancerinsaudipatientsagedbelow60yearsandabove60years AT tunioma comparativeclinicopathologicalandoutcomeanalysisofdifferentiatedthyroidcancerinsaudipatientsagedbelow60yearsandabove60years AT asirima comparativeclinicopathologicalandoutcomeanalysisofdifferentiatedthyroidcancerinsaudipatientsagedbelow60yearsandabove60years AT bayoumiy comparativeclinicopathologicalandoutcomeanalysisofdifferentiatedthyroidcancerinsaudipatientsagedbelow60yearsandabove60years AT balbaida comparativeclinicopathologicalandoutcomeanalysisofdifferentiatedthyroidcancerinsaudipatientsagedbelow60yearsandabove60years AT aljohaninj comparativeclinicopathologicalandoutcomeanalysisofdifferentiatedthyroidcancerinsaudipatientsagedbelow60yearsandabove60years AT fatanih comparativeclinicopathologicalandoutcomeanalysisofdifferentiatedthyroidcancerinsaudipatientsagedbelow60yearsandabove60years |
_version_ |
1718403355416461312 |